NATR
NATURES SUNSHINE PRODUCTS INC
Company overview
- Market capitalization
- $225.75M
- Employees
- 806
- Latest publication
- 2026-09-29
About NATURES SUNSHINE PRODUCTS INC
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 122,892,000USD | 123,807,000USD | 128,339,000USD | 114,750,000USD | 113,248,000USD | 118,205,000USD | 114,615,000USD | 110,551,000USD |
| Cost Of Revenue | 32,915,000USD | 34,028,000USD | 34,290,000USD | 32,451,000USD | 31,651,000USD | 33,141,000USD | 32,856,000USD | 31,664,000USD |
| Gross Profit | 89,977,000USD | 89,779,000USD | 94,049,000USD | 82,299,000USD | 81,597,000USD | 85,064,000USD | 81,759,000USD | 78,887,000USD |
| Selling General Administrative | 43,539,000USD | 48,418,000USD | 45,726,000USD | 43,665,000USD | 40,581,000USD | 43,709,000USD | 40,954,000USD | 38,557,000USD |
| Selling And Marketing Expenses | 36,893,000USD | 36,039,000USD | 39,348,000USD | 34,360,000USD | 34,844,000USD | 36,805,000USD | 35,521,000USD | 34,693,000USD |
| Total Operating Expenses | 80,432,000USD | 84,457,000USD | 85,074,000USD | 78,025,000USD | 75,425,000USD | 80,514,000USD | 76,475,000USD | 73,250,000USD |
| Operating Income | 9,545,000USD | 5,322,000USD | 8,975,000USD | 4,274,000USD | 6,172,000USD | 4,550,000USD | 5,284,000USD | 5,637,000USD |
| Interest Income | 74,000USD | 121,000USD | 51,000USD | 268,000USD | 205,000USD | — | — | 412,000USD |
| Interest Expense | 35,000USD | 27,000USD | 26,000USD | 24,000USD | 21,000USD | — | 39,000USD | 103,000USD |
| Net Interest Income | 39,000USD | 94,000USD | 25,000USD | 244,000USD | 184,000USD | — | -39,000USD | 309,000USD |
| Income Before Tax | 8,155,000USD | 5,487,000USD | 9,672,000USD | 7,544,000USD | 7,109,000USD | 1,449,000USD | 7,899,000USD | 4,423,000USD |
| Income Tax Expense | 3,037,000USD | 974,000USD | 4,136,999USD | 2,025,000USD | 2,225,000USD | 2,181,000USD | 3,253,000USD | 2,935,000USD |
| Tax Provision | 3,037,000USD | 974,000USD | 4,137,000USD | 2,025,000USD | 2,225,000USD | 2,181,000USD | 3,253,000USD | 2,935,000USD |
| Net Income | 5,118,000USD | 4,107,000USD | 5,334,000USD | 5,333,000USD | 4,747,000USD | -321,000USD | 4,347,000USD | 1,349,000USD |
| Net Income From Continuing Ops | 5,118,000USD | 4,513,000USD | 5,535,000USD | 5,519,000USD | 4,884,000USD | -732,000USD | 4,646,000USD | 1,488,000USD |
| Ebit | 8,190,000USD | 5,514,000USD | 9,672,000USD | 7,568,000USD | 7,130,000USD | 3,027,000USD | 7,899,000USD | 4,423,000USD |
| Ebitda | 11,414,000USD | 8,820,000USD | 13,211,000USD | 11,068,000USD | 10,629,000USD | 7,051,000USD | 11,435,000USD | 7,922,000USD |
| Depreciation And Amortization | 3,224,000USD | 3,306,000USD | 3,539,000USD | 3,500,000USD | 3,499,000USD | 4,024,000USD | 3,536,000USD | 3,499,000USD |
| Reconciled Depreciation | 3,224,000USD | 3,306,000USD | 3,539,000USD | 3,500,000USD | 3,499,000USD | 4,024,000USD | 3,536,000USD | 3,499,000USD |
| Total Other Income Expense Net | -1,390,000USD | 165,000USD | 697,000USD | 3,270,000USD | 937,000USD | -3,101,000USD | 2,615,000USD | -1,214,000USD |
| Minority Interest | 0USD | -406,000USD | -201,000USD | -186,000USD | -137,000USD | 411,000USD | -299,000USD | -139,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 480,144,000USD | 454,364,000USD | 421,910,000USD | 362,215,000USD | 364,810,000USD | 342,029,000USD | 366,367,000USD | 378,096,000USD |
| Cost Of Revenue | 132,420,000USD | 129,676,000USD | 122,150,000USD | 93,940,000USD | 95,691,000USD | 91,037,000USD | 91,584,000USD | 94,814,000USD |
| Gross Profit | 347,724,000USD | 324,688,000USD | 299,760,000USD | 268,275,000USD | 269,119,000USD | 250,992,000USD | 274,783,000USD | 283,282,000USD |
| Research Development | 1,900,000USD | 1,700,000USD | 1,500,000USD | 2,100,000USD | 2,800,000USD | 3,400,000USD | 2,500,000USD | 2,000,000USD |
| Selling General Administrative | 178,390,000USD | 164,004,000USD | 153,125,000USD | 128,740,000USD | 138,431,000USD | 129,635,000USD | 119,927,000USD | 120,743,000USD |
| Selling And Marketing Expenses | 144,591,000USD | 140,589,000USD | 130,377,000USD | 123,410,000USD | — | — | 135,808,000USD | 138,482,000USD |
| Total Operating Expenses | 322,981,000USD | 304,593,000USD | 283,502,000USD | 252,150,000USD | 263,768,000USD | 249,605,000USD | 255,735,000USD | 259,225,000USD |
| Operating Income | 24,743,000USD | 20,095,000USD | 16,258,000USD | 16,125,000USD | 5,351,000USD | 1,387,000USD | 19,048,000USD | 24,057,000USD |
| Interest Income | 645,000USD | 177,000USD | 123,000USD | 262,000USD | 67,000USD | 144,000USD | — | — |
| Interest Expense | 98,000USD | 146,000USD | 249,000USD | 43,000USD | 387,000USD | 289,000USD | 187,000USD | 231,000USD |
| Net Interest Income | 547,000USD | 31,000USD | -126,000USD | 219,000USD | -387,000USD | -145,000USD | — | — |
| Income Before Tax | 29,812,000USD | 18,426,000USD | 15,215,000USD | 15,642,000USD | 3,200,000USD | 3,222,000USD | 19,014,000USD | 25,653,000USD |
| Income Tax Expense | 9,361,000USD | 10,534,000USD | 14,665,000USD | 8,713,000USD | 4,402,000USD | 17,039,000USD | -743,000USD | 8,044,000USD |
| Tax Provision | 9,361,000USD | 10,534,000USD | 14,665,000USD | 8,713,000USD | 4,402,000USD | 17,039,000USD | — | — |
| Net Income | 19,521,000USD | 7,696,000USD | -390,000USD | 6,765,000USD | -854,000USD | -12,942,000USD | 10,019,000USD | 17,609,000USD |
| Net Income From Continuing Ops | 20,451,000USD | 7,892,000USD | 550,000USD | 6,929,000USD | -1,202,000USD | -13,817,000USD | 19,757,000USD | 17,609,000USD |
| Ebit | 29,910,000USD | 18,572,000USD | 15,464,000USD | 15,685,000USD | 3,587,000USD | 1,387,000USD | 21,248,000USD | 26,283,000USD |
| Ebitda | 43,754,000USD | 32,791,000USD | 31,146,000USD | 26,284,000USD | 13,487,000USD | 10,021,000USD | 25,657,000USD | 30,749,000USD |
| Depreciation And Amortization | 13,844,000USD | 14,219,000USD | 15,682,000USD | 10,599,000USD | 9,900,000USD | 8,634,000USD | 4,409,000USD | 4,466,000USD |
| Reconciled Depreciation | 13,844,000USD | 14,219,000USD | 11,025,000USD | 10,599,000USD | 9,806,000USD | 8,634,000USD | — | — |
| Total Other Income Expense Net | 5,069,000USD | -1,669,000USD | -1,043,000USD | -483,000USD | -2,151,000USD | 1,835,000USD | -34,000USD | 1,596,000USD |
| Minority Interest | -930,000USD | -196,000USD | 940,000USD | 164,000USD | -348,000USD | -875,000USD | -219,000USD | — |
| Non Operating Income Net Other | — | — | -1,043,000USD | -483,000USD | -2,151,000USD | 1,835,000USD | -34,000USD | 1,596,000USD |
| Net Income Applicable To Common Shares | — | — | -390,000USD | 6,765,000USD | -854,000USD | -12,942,000USD | 10,019,000USD | 17,609,000USD |
| Unclassified Operating Expenses | — | — | — | — | 122,537,000USD | 116,570,000USD | — | — |
| Discontinued Operations | — | — | — | — | — | — | -9,957,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 261,458,000USD | 261,146,000USD | 264,805,000USD | 254,875,000USD | 252,702,000USD | 240,855,000USD | 245,333,000USD | 235,831,000USD |
| Other Current Assets | 11,330,000USD | 8,040,000USD | 8,081,000USD | 8,144,000USD | 7,955,000USD | 6,959,000USD | 11,131,000USD | 9,747,000USD |
| Total Liab | 94,542,000USD | 99,593,000USD | 98,101,000USD | 91,193,000USD | 85,602,000USD | 79,864,000USD | 82,716,000USD | 79,431,000USD |
| Total Stockholder Equity | 166,916,000USD | 161,553,000USD | 160,502,000USD | 157,681,000USD | 161,285,000USD | 155,313,000USD | 156,528,000USD | 150,610,000USD |
| Other Current Liab | 50,999,000USD | 56,704,000USD | 56,794,000USD | 50,039,000USD | 47,556,000USD | 43,637,000USD | 45,969,000USD | 45,138,000USD |
| Common Stock | 102,252,000USD | 102,192,000USD | 103,553,000USD | 104,662,000USD | 115,146,000USD | 114,577,000USD | 113,946,000USD | 114,014,000USD |
| Capital Stock | 102,252,000USD | 102,192,000USD | 103,553,000USD | 104,662,000USD | 115,146,000USD | 114,577,000USD | 113,946,000USD | 114,014,000USD |
| Retained Earnings | 82,046,000USD | 76,928,000USD | 72,821,000USD | 67,487,000USD | 62,154,000USD | 57,407,000USD | 57,728,000USD | 53,381,000USD |
| Cash | 87,578,000USD | 93,891,000USD | 95,554,000USD | 81,345,000USD | 86,486,000USD | 84,700,000USD | 78,704,000USD | 68,695,000USD |
| Cash And Short Term Investments | 87,578,000USD | 93,891,000USD | 95,554,000USD | 81,345,000USD | 86,486,000USD | 84,700,000USD | 78,704,000USD | 68,695,000USD |
| Total Current Assets | 178,588,000USD | 178,845,000USD | 186,084,000USD | 171,838,000USD | 170,782,000USD | 160,579,000USD | 163,529,000USD | 152,036,000USD |
| Total Current Liabilities | 71,366,000USD | 78,538,000USD | 83,649,000USD | 75,854,000USD | 70,741,000USD | 65,692,000USD | 67,150,000USD | 63,649,000USD |
| Current Deferred Revenue | 2,780,000USD | 5,840,000USD | 7,536,000USD | 5,501,000USD | 2,487,000USD | 2,774,000USD | 1,747,000USD | 2,217,000USD |
| Net Debt | -65,148,000USD | -74,991,000USD | -81,266,000USD | -65,715,000USD | -71,638,000USD | -70,496,000USD | -63,430,000USD | -53,344,000USD |
| Short Term Debt | 4,367,000USD | 3,270,000USD | 4,601,000USD | 4,625,000USD | 4,291,000USD | 3,927,000USD | 4,037,000USD | 3,961,000USD |
| Short Long Term Debt Total | 22,430,000USD | 18,900,000USD | 14,288,000USD | 15,630,000USD | 14,848,000USD | 14,204,000USD | 15,274,000USD | 15,351,000USD |
| Net Receivables | 12,549,000USD | 8,602,000USD | 15,114,000USD | 13,029,000USD | 11,413,000USD | 9,477,000USD | 11,396,000USD | 11,290,000USD |
| Inventory | 67,131,000USD | 68,312,000USD | 67,335,000USD | 69,320,000USD | 64,928,000USD | 59,443,000USD | 62,298,000USD | 62,304,000USD |
| Accounts Payable | 8,251,000USD | 8,021,000USD | 7,119,000USD | 9,924,000USD | 9,865,000USD | 8,912,000USD | 8,875,000USD | 8,422,000USD |
| Property Plant Equipment Net | 51,788,000USD | 50,515,000USD | 46,935,000USD | 50,148,000USD | 51,162,000USD | 52,384,000USD | 55,809,000USD | 58,554,000USD |
| Property Plant Equipment Gross | 51,788,000USD | 158,659,000USD | 46,935,000USD | 50,148,000USD | 51,162,000USD | 150,212,000USD | 55,809,000USD | 58,554,000USD |
| Accumulated Other Comprehensive Income | -17,382,000USD | -17,566,999USD | -15,872,000USD | -14,468,000USD | -16,015,000USD | -16,671,000USD | -15,146,000USD | -16,785,000USD |
| Common Stock Shares Outstanding | 17,929,000shares | 17,922,000shares | 18,034,000shares | 18,966,000shares | 18,846,000shares | 18,479,000shares | 18,890,000shares | 19,119,000shares |
| Non Current Assets Total | 82,870,000USD | 82,301,000USD | 78,721,000USD | 83,037,000USD | 81,920,000USD | 80,276,000USD | 81,804,000USD | 83,795,000USD |
| Non Current Liabilities Total | 23,176,000USD | 21,055,000USD | 14,452,000USD | 15,339,000USD | 14,861,000USD | 14,172,000USD | 15,566,000USD | 15,782,000USD |
| Non Current Liabilities Other | 2,605,000USD | 2,911,000USD | 2,139,000USD | 1,646,000USD | 1,580,000USD | 1,345,000USD | 1,440,000USD | 1,403,000USD |
| Non Currrent Assets Other | 10,396,000USD | 10,586,000USD | 11,426,000USD | 11,479,000USD | 10,739,000USD | 10,248,000USD | 10,162,000USD | 9,647,000USD |
| Net Working Capital | 107,222,000USD | 100,307,000USD | 102,435,000USD | 95,984,000USD | 100,041,000USD | 94,887,000USD | 96,379,000USD | 88,387,000USD |
| Unclassified Non Current Assets | 20,686,000USD | 21,200,000USD | 20,360,000USD | 21,410,000USD | 20,019,000USD | 17,644,000USD | 14,941,000USD | 14,703,999USD |
| Unclassified Current Liabilities | 4,969,000USD | 4,703,000USD | 7,599,000USD | 5,765,000USD | 6,542,000USD | 6,442,000USD | 6,522,000USD | 3,911,000USD |
| Unclassified Non Current Liabilities | 20,571,000USD | 18,144,000USD | 12,313,000USD | 13,693,000USD | 13,281,000USD | 12,827,000USD | 14,126,000USD | 14,379,000USD |
| Unclassified Equity | -102,252,000USD | -102,192,001USD | -103,553,000USD | -104,662,000USD | -115,146,000USD | -114,577,000USD | -113,946,000USD | -114,014,000USD |
| Long Term Investments | — | — | — | — | — | — | 892,000USD | 890,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 261,146,000USD | 240,855,000USD | 249,773,000USD | 229,778,000USD | 258,874,000USD | 249,498,000USD | 213,068,000USD | 193,016,000USD |
| Other Current Assets | 8,040,000USD | 6,959,000USD | 7,722,000USD | 7,420,000USD | 8,760,000USD | 6,938,000USD | 5,091,000USD | 6,388,000USD |
| Total Liab | 99,593,000USD | 79,864,000USD | 90,233,000USD | 82,731,000USD | 97,470,000USD | 92,264,000USD | 83,632,000USD | 72,448,000USD |
| Total Stockholder Equity | 161,553,000USD | 155,313,000USD | 154,058,000USD | 142,905,000USD | 158,202,000USD | 155,386,000USD | 129,209,000USD | 120,505,000USD |
| Other Current Liab | 56,704,000USD | 43,637,000USD | 52,739,000USD | 44,667,000USD | 51,562,000USD | 47,935,000USD | 41,594,000USD | 55,363,000USD |
| Common Stock | 102,192,000USD | 114,577,000USD | 119,694,000USD | 121,583,000USD | 133,382,000USD | 139,311,000USD | 135,741,000USD | 133,684,000USD |
| Capital Stock | 102,192,000USD | 114,577,000USD | 119,694,000USD | 121,583,000USD | 133,382,000USD | 139,311,000USD | 135,741,000USD | 133,684,000USD |
| Retained Earnings | 76,928,000USD | 57,407,000USD | 49,711,000USD | 34,635,000USD | 35,025,000USD | 26,030,000USD | 4,693,000USD | -2,072,000USD |
| Cash | 93,891,000USD | 84,700,000USD | 82,373,000USD | 60,032,000USD | 86,184,000USD | 92,069,000USD | 53,629,000USD | 50,638,000USD |
| Cash And Short Term Investments | 93,891,000USD | 84,700,000USD | 82,373,000USD | 60,032,000USD | 86,184,000USD | 92,069,000USD | 53,629,000USD | 50,638,000USD |
| Total Current Assets | 178,845,000USD | 160,579,000USD | 165,817,000USD | 149,507,000USD | 164,667,000USD | 154,065,000USD | 112,705,000USD | 106,825,000USD |
| Total Current Liabilities | 78,538,000USD | 65,692,000USD | 76,753,000USD | 65,582,000USD | 76,670,000USD | 69,654,000USD | 57,947,000USD | 66,687,000USD |
| Current Deferred Revenue | 5,840,000USD | 2,774,000USD | 1,794,000USD | 2,255,000USD | 3,694,000USD | 2,092,000USD | 1,266,000USD | 1,197,000USD |
| Net Debt | -74,991,000USD | -70,496,000USD | -67,450,000USD | -40,847,000USD | -63,195,000USD | -65,741,000USD | -26,957,000USD | -49,108,000USD |
| Short Term Debt | 3,270,000USD | 3,927,000USD | 4,547,000USD | 5,440,000USD | 5,896,000USD | 7,498,000USD | 6,459,000USD | 1,530,000USD |
| Short Long Term Debt Total | 18,900,000USD | 14,204,000USD | 14,923,000USD | 19,185,000USD | 22,989,000USD | 26,328,000USD | 26,672,000USD | 1,530,000USD |
| Net Receivables | 8,602,000USD | 9,477,000USD | 8,827,000USD | 14,106,000USD | 8,871,000USD | 7,375,000USD | 7,319,000USD | 7,751,000USD |
| Inventory | 68,312,000USD | 59,443,000USD | 66,895,000USD | 67,949,000USD | 60,852,000USD | 47,683,000USD | 46,666,000USD | 42,048,000USD |
| Accounts Payable | 8,021,000USD | 8,912,000USD | 7,910,000USD | 6,349,000USD | 9,702,000USD | 6,486,000USD | 4,406,000USD | 5,219,000USD |
| Property Plant Equipment Net | 50,515,000USD | 52,384,000USD | 58,361,000USD | 62,307,000USD | 69,206,000USD | 74,565,000USD | 83,463,000USD | 64,061,000USD |
| Property Plant Equipment Gross | 158,659,000USD | 150,212,000USD | 153,117,000USD | 62,307,000USD | 69,206,000USD | 74,565,000USD | 83,463,000USD | 64,061,000USD |
| Accumulated Other Comprehensive Income | -17,566,999USD | -16,671,000USD | -15,347,000USD | -13,313,000USD | -10,205,000USD | -9,955,000USD | -11,225,000USD | -11,107,000USD |
| Common Stock Shares Outstanding | 18,468,000shares | 18,616,000shares | 19,466,000shares | 19,326,000shares | 20,327,000shares | 19,968,000shares | 19,663,000shares | 19,123,000shares |
| Non Current Assets Total | 82,301,000USD | 80,276,000USD | 83,956,000USD | 80,271,000USD | 94,207,000USD | 95,433,000USD | 100,363,000USD | 86,191,000USD |
| Non Current Liabilities Total | 21,055,000USD | 14,172,000USD | 13,480,000USD | 17,149,000USD | 20,800,000USD | 22,610,000USD | 25,685,000USD | 5,761,000USD |
| Non Current Liabilities Other | 2,911,000USD | 1,345,000USD | 644,000USD | 15,008,000USD | 17,096,000USD | 16,412,000USD | 20,213,000USD | 2,897,000USD |
| Non Currrent Assets Other | 10,586,000USD | 10,248,000USD | 10,531,000USD | 11,105,000USD | 11,411,000USD | 12,175,000USD | 11,434,000USD | 11,148,000USD |
| Net Working Capital | 100,307,000USD | 94,887,000USD | 89,064,000USD | 83,925,000USD | 87,997,000USD | 84,411,000USD | 54,758,000USD | 40,138,000USD |
| Unclassified Non Current Assets | 21,200,000USD | 17,644,000USD | 15,063,999USD | -12,643,000USD | -11,411,000USD | -12,175,000USD | -11,434,000USD | -12,456,000USD |
| Unclassified Current Liabilities | 4,703,000USD | 6,442,000USD | 9,763,000USD | 5,697,000USD | 4,270,000USD | 3,137,000USD | 2,704,000USD | 1,848,000USD |
| Unclassified Non Current Liabilities | 18,144,000USD | 12,827,000USD | 12,836,000USD | -3,404,000USD | -3,707,000USD | — | — | -2,897,000USD |
| Unclassified Equity | -102,192,001USD | -114,577,000USD | -119,694,000USD | -121,583,000USD | -133,382,000USD | -139,311,000USD | -135,741,000USD | -133,684,000USD |
| Other Assets | — | — | 1USD | 17,964,000USD | 25,001,000USD | 20,868,000USD | 16,333,000USD | 21,512,000USD |
| Intangible Assets | — | — | — | 1,538,000USD | — | — | 567,000USD | 618,000USD |
| Deferred Long Term Liab | — | — | — | 2,141,000USD | 2,530,000USD | — | — | — |
| Other Liab | — | — | — | 3,404,000USD | 3,707,000USD | 3,780,000USD | 5,472,000USD | 5,761,000USD |
| Short Long Term Debt | — | — | — | 1,174,000USD | 1,546,000USD | 2,506,000USD | 1,518,000USD | 1,530,000USD |
| Short Term Investments | — | — | — | 3,858,000USD | — | 989,000USD | — | — |
| Net Tangible Assets | — | — | — | 142,905,000USD | 158,202,000USD | 155,386,000USD | 128,642,000USD | 119,887,000USD |
| Unclassified Current Assets | — | — | — | -3,858,000USD | — | — | — | — |
| Long Term Debt | — | — | — | — | 1,174,000USD | 2,418,000USD | — | — |
| Long Term Investments | — | — | — | — | — | — | — | 1,308,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 5,118,000USD | 5,535,000USD | 5,519,000USD | 4,884,000USD | -321,000USD | 4,347,000USD | 1,488,000USD | 2,490,000USD |
| Depreciation | 3,224,000USD | 3,539,000USD | 3,500,000USD | 3,499,000USD | 4,024,000USD | 3,536,000USD | 3,499,000USD | 3,160,000USD |
| Stock Based Compensation | 1,639,000USD | 1,285,000USD | 1,638,000USD | 1,300,000USD | 1,208,000USD | 950,000USD | 1,261,000USD | 1,369,000USD |
| Other Non Cash Items | 2,294,000USD | 379,000USD | -1,933,000USD | 703,000USD | 4,858,000USD | 1,011,000USD | 3,537,000USD | 1,162,000USD |
| Change To Account Receivables | -4,094,000USD | -2,291,000USD | -1,177,000USD | -1,786,000USD | 1,442,000USD | 397,000USD | -1,824,000USD | -1,136,000USD |
| Change To Inventory | 444,000USD | 1,473,000USD | -2,848,000USD | -5,053,000USD | 1,170,000USD | 1,280,000USD | -277,000USD | 3,389,000USD |
| Change In Working Capital | -14,798,000USD | 6,661,000USD | -3,187,000USD | -5,795,000USD | 5,311,000USD | 685,000USD | -8,623,000USD | -5,834,000USD |
| Total Cash From Operating Activities | -1,846,000USD | 18,474,000USD | 4,340,000USD | 2,609,000USD | 12,184,000USD | 9,619,000USD | 1,305,000USD | 2,190,000USD |
| Capital Expenditures | -2,480,000USD | -1,683,000USD | -1,350,000USD | -1,110,000USD | -2,195,000USD | -1,736,000USD | -3,351,000USD | -3,689,000USD |
| Free Cash Flow | -4,326,000USD | 16,791,000USD | 2,990,000USD | 1,499,000USD | 9,989,000USD | 7,883,000USD | -2,046,000USD | -1,499,000USD |
| Total Cashflows From Investing Activities | -2,480,000USD | -1,683,000USD | -1,350,000USD | -1,110,000USD | -2,195,000USD | -1,736,000USD | -3,351,000USD | -3,689,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Total Cash From Financing Activities | -1,579,000USD | -2,395,000USD | -12,122,000USD | -731,000USD | -576,000USD | -1,018,000USD | -8,418,000USD | 107,000USD |
| Sale Purchase Of Stock | -500,000USD | -2,022,000USD | -11,878,000USD | -476,000USD | -423,000USD | -711,000USD | -5,877,000USD | -1,848,000USD |
| Change In Cash | -6,313,000USD | 14,209,000USD | -5,141,000USD | 1,786,000USD | 5,996,000USD | 10,009,000USD | -9,078,000USD | -4,600,000USD |
| Begin Period Cash Flow | 93,891,000USD | 81,345,000USD | 86,486,000USD | 84,700,000USD | 78,704,000USD | 68,695,000USD | 77,773,000USD | 82,373,000USD |
| End Period Cash Flow | 87,578,000USD | 95,554,000USD | 81,345,000USD | 86,486,000USD | 84,700,000USD | 78,704,000USD | 68,695,000USD | 77,773,000USD |
| Other Cashflows From Investing Activities | 182,000USD | 80,000USD | -559,000USD | — | — | 38,000USD | — | -7,000USD |
| Other Cashflows From Financing Activities | -1,079,000USD | -373,000USD | -244,000USD | -255,000USD | -153,000USD | -307,000USD | -434,000USD | -152,000USD |
| Investments | — | -1,683,000USD | -1,350,000USD | -1,110,000USD | -2,195,000USD | -1,736,000USD | -3,351,000USD | -3,689,000USD |
| Unclassified Operating Cash Flow | — | 1,075,000USD | -1,197,000USD | -1,982,000USD | -2,896,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | 1,603,000USD | 1,909,000USD | 1,110,000USD | 2,195,000USD | 1,698,000USD | 3,351,000USD | 3,696,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | -2,107,000USD | 2,107,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 20,451,000USD | 7,892,000USD | 15,076,000USD | 550,000USD | 30,207,000USD | 22,958,000USD | 6,929,000USD | -1,202,000USD |
| Depreciation | 13,844,000USD | 14,219,000USD | 11,816,000USD | 11,000,000USD | 11,162,000USD | 10,743,000USD | 10,599,000USD | 9,806,000USD |
| Stock Based Compensation | 5,780,000USD | 4,788,000USD | 4,893,000USD | 2,901,000USD | 3,731,000USD | 3,787,000USD | 2,120,000USD | 2,170,000USD |
| Other Non Cash Items | 609,000USD | 8,522,000USD | 4,789,000USD | 6,975,000USD | 8,377,000USD | 3,735,000USD | 6,306,000USD | -778,000USD |
| Change To Account Receivables | 1,015,000USD | -1,121,000USD | 4,921,000USD | -5,942,000USD | -1,681,000USD | 106,000USD | 375,000USD | 189,000USD |
| Change To Inventory | -7,824,000USD | 5,562,000USD | 995,000USD | -8,841,000USD | -14,456,000USD | -154,000USD | -4,870,000USD | 1,066,000USD |
| Change In Working Capital | -3,090,000USD | -8,461,000USD | 13,177,000USD | -27,319,000USD | -14,740,000USD | 793,000USD | -21,688,000USD | 11,855,000USD |
| Total Cash From Operating Activities | 35,321,000USD | 25,298,000USD | 41,226,000USD | 710,000USD | 34,608,000USD | 37,659,000USD | 8,545,000USD | 21,833,000USD |
| Capital Expenditures | -6,480,000USD | -10,971,000USD | -10,478,000USD | -7,628,000USD | -6,666,000USD | -4,905,000USD | -5,104,000USD | -4,834,000USD |
| Free Cash Flow | 28,841,000USD | 14,327,000USD | 30,748,000USD | -6,918,000USD | 27,942,000USD | 32,754,000USD | 3,441,000USD | 16,999,000USD |
| Total Cashflows From Investing Activities | -6,480,000USD | -10,971,000USD | -10,478,000USD | -7,628,000USD | -6,612,000USD | -4,905,000USD | -5,102,000USD | 211,000USD |
| Net Borrowings | 0USD | 0USD | -1,174,000USD | -1,546,000USD | -2,203,000USD | 3,406,000USD | 3,406,000USD | -12,181,000USD |
| Total Cash From Financing Activities | -23,773,000USD | -9,905,000USD | -7,956,000USD | -16,246,000USD | -31,721,000USD | 3,878,000USD | -63,000USD | -12,192,000USD |
| Sale Purchase Of Stock | -16,309,000USD | -8,859,000USD | -6,397,000USD | -13,571,000USD | -7,425,000USD | 0USD | 257,000USD | 664,000USD |
| Change In Cash | 9,191,000USD | 2,327,000USD | 22,341,000USD | -26,152,000USD | -5,885,000USD | 38,440,000USD | 2,991,000USD | 7,728,000USD |
| Begin Period Cash Flow | 84,700,000USD | 82,373,000USD | 60,032,000USD | 86,184,000USD | 92,069,000USD | 53,629,000USD | 50,638,000USD | 42,910,000USD |
| End Period Cash Flow | 93,891,000USD | 84,700,000USD | 82,373,000USD | 60,032,000USD | 86,184,000USD | 92,069,000USD | 53,629,000USD | 50,638,000USD |
| Other Cashflows From Investing Activities | -6,480,000USD | -10,971,000USD | — | -7,628,000USD | 54,000USD | — | 2,000USD | 5,045,000USD |
| Other Cashflows From Financing Activities | -7,464,000USD | -1,046,000USD | -385,000USD | -1,129,000USD | -2,235,000USD | 472,000USD | -63,000USD | -11,000USD |
| Unclassified Operating Cash Flow | -2,273,000USD | -1,662,000USD | -8,525,000USD | 6,603,000USD | -4,129,000USD | -4,357,000USD | 4,279,000USD | — |
| Unclassified Investing Cash Flow | 6,480,000USD | 21,942,000USD | 12,128,000USD | 15,256,000USD | 6,612,000USD | 4,905,000USD | 5,102,000USD | — |
| Investments | — | -10,971,000USD | -12,128,000USD | -7,628,000USD | -6,612,000USD | -4,905,000USD | -5,102,000USD | 211,000USD |
| Change To Liabilities | — | — | — | -6,985,000USD | 3,089,000USD | 8,102,000USD | -11,513,000USD | 12,377,000USD |
| Dividends Paid | — | — | — | -3,102,000USD | -19,858,000USD | -19,858,000USD | -19,858,000USD | -19,858,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -23,164,000USD | -3,725,000USD | 36,632,000USD | 3,380,000USD | 7,728,000USD |
| Unclassified Financing Cash Flow | — | — | — | 3,102,000USD | — | 19,858,000USD | 16,195,000USD | 19,194,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -2,124,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Cardiovascular Products | 20,341,000 | USD | 0001628280-26-032316 |
| Q1 2026Quarterly · 2026-03-31 | Product | Digestive Products | 32,499,000 | USD | 0001628280-26-032316 |
| Q1 2026Quarterly · 2026-03-31 | Product | General Health Products | 49,070,000 | USD | 0001628280-26-032316 |
| Q1 2026Quarterly · 2026-03-31 | Product | Immunity Products | 10,145,000 | USD | 0001628280-26-032316 |
| Q1 2026Quarterly · 2026-03-31 | Product | Personal Care Products | 6,977,000 | USD | 0001628280-26-032316 |
| Q1 2026Quarterly · 2026-03-31 | Product | Weight Management Products | 3,860,000 | USD | 0001628280-26-032316 |
| Q4 2025Quarterly · 2025-12-31 | Product | Cardiovascular Products | 18,697,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Digestive Products | 37,558,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | General Health Products | 46,936,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Immunity Products | 9,722,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Personal Care Products | 7,567,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Weight Management Products | 3,327,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Cardiovascular Products | 81,635,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | Digestive Products | 124,368,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | General Health Products | 192,122,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | Immunity Products | 40,818,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | Personal Care Products | 23,267,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | Shipping And Handling | 2,500,000 | USD | 0001628280-26-016540 |
| FY 2025Yearly · 2025-12-31 | Product | Weight Management Products | 17,934,000 | USD | 0001628280-26-016540 |
| Q3 2025Quarterly · 2025-09-30 | Product | Cardiovascular Products | 22,965,000 | USD | 0000275053-25-000004 |
| Q3 2025Quarterly · 2025-09-30 | Product | Digestive Products | 31,370,000 | USD | 0000275053-25-000004 |
| Q3 2025Quarterly · 2025-09-30 | Product | General Health Products | 51,886,000 | USD | 0000275053-25-000004 |
| Q3 2025Quarterly · 2025-09-30 | Product | Immunity Products | 10,735,000 | USD | 0000275053-25-000004 |
| Q3 2025Quarterly · 2025-09-30 | Product | Personal Care Products | 5,847,000 | USD | 0000275053-25-000004 |
| Q3 2025Quarterly · 2025-09-30 | Product | Weight Management Products | 5,536,000 | USD | 0000275053-25-000004 |
| Q2 2025Quarterly · 2025-06-30 | Product | Cardiovascular Products | 19,460,000 | USD | 0001628280-25-037065 |
| Q2 2025Quarterly · 2025-06-30 | Product | Digestive Products | 27,910,000 | USD | 0001628280-25-037065 |
| Q2 2025Quarterly · 2025-06-30 | Product | General Health Products | 47,376,000 | USD | 0001628280-25-037065 |
| Q2 2025Quarterly · 2025-06-30 | Product | Immunity Products | 10,086,000 | USD | 0001628280-25-037065 |
| Q2 2025Quarterly · 2025-06-30 | Product | Personal Care Products | 5,305,000 | USD | 0001628280-25-037065 |
| Q2 2025Quarterly · 2025-06-30 | Product | Weight Management Products | 4,613,000 | USD | 0001628280-25-037065 |
| Q1 2025Quarterly · 2025-03-31 | Product | Cardiovascular Products | 20,513,000 | USD | 0001628280-26-032316 |
| Q1 2025Quarterly · 2025-03-31 | Product | Digestive Products | 27,530,000 | USD | 0001628280-26-032316 |
| Q1 2025Quarterly · 2025-03-31 | Product | General Health Products | 45,924,000 | USD | 0001628280-26-032316 |
| Q1 2025Quarterly · 2025-03-31 | Product | Immunity Products | 10,275,000 | USD | 0001628280-26-032316 |
| Q1 2025Quarterly · 2025-03-31 | Product | Personal Care Products | 4,548,000 | USD | 0001628280-26-032316 |
| Q1 2025Quarterly · 2025-03-31 | Product | Weight Management Products | 4,458,000 | USD | 0001628280-26-032316 |
| Q4 2024Quarterly · 2024-12-31 | Product | Cardiovascular Products | 19,131,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Digestive Products | 34,619,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | General Health Products | 46,070,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Immunity Products | 12,483,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Personal Care Products | 5,595,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Weight Management Products | 307,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Cardiovascular Products | 81,700,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | Digestive Products | 111,744,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | General Health Products | 183,882,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | Immunity Products | 38,724,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | Personal Care Products | 17,803,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | Shipping And Handling | 2,100,000 | USD | 0001628280-26-016540 |
| FY 2024Yearly · 2024-12-31 | Product | Weight Management Products | 20,511,000 | USD | 0001628280-26-016540 |
| Q3 2024Quarterly · 2024-09-30 | Product | Cardiovascular Products | 21,631,000 | USD | 0000275053-25-000004 |
| Q3 2024Quarterly · 2024-09-30 | Product | Digestive Products | 26,009,000 | USD | 0000275053-25-000004 |
| Q3 2024Quarterly · 2024-09-30 | Product | General Health Products | 48,778,000 | USD | 0000275053-25-000004 |
| Q3 2024Quarterly · 2024-09-30 | Product | Immunity Products | 8,468,000 | USD | 0000275053-25-000004 |
| Q3 2024Quarterly · 2024-09-30 | Product | Personal Care Products | 3,761,000 | USD | 0000275053-25-000004 |
| Q3 2024Quarterly · 2024-09-30 | Product | Weight Management Products | 5,968,000 | USD | 0000275053-25-000004 |
| Q2 2024Quarterly · 2024-06-30 | Product | Cardiovascular Products | 20,079,000 | USD | 0001628280-25-037065 |
| Q2 2024Quarterly · 2024-06-30 | Product | Digestive Products | 24,697,000 | USD | 0001628280-25-037065 |
| Q2 2024Quarterly · 2024-06-30 | Product | General Health Products | 45,261,000 | USD | 0001628280-25-037065 |
| Q2 2024Quarterly · 2024-06-30 | Product | Immunity Products | 8,586,000 | USD | 0001628280-25-037065 |
| Q2 2024Quarterly · 2024-06-30 | Product | Personal Care Products | 4,040,000 | USD | 0001628280-25-037065 |
| Q2 2024Quarterly · 2024-06-30 | Product | Weight Management Products | 7,888,000 | USD | 0001628280-25-037065 |
| FY 2023Yearly · 2023-12-31 | Product | Cardiovascular Products | 83,591,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | Digestive Products | 103,866,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | General Health Products | 173,774,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | Immunity Products | 32,469,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | Personal Care Products | 18,301,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | Shipping And Handling | 1,400,000 | USD | 0001628280-25-012082 |
| FY 2023Yearly · 2023-12-31 | Product | Weight Management Products | 33,319,000 | USD | 0001628280-25-012082 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Countries | 188,188,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Geography | South Korea | 62,041,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 134,976,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Segment | Asia Business | 138,717,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Segment | Europe Business | 77,688,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Segment | Latin America And Other Business Segments | 23,319,000 | USD | 0000275053-21-000002 |
| FY 2020Yearly · 2020-12-31 | Segment | North America Business | 145,481,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Countries | 163,640,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Geography | South Korea | 70,556,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 128,019,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Segment | Asia Business | 138,536,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Segment | Europe Business | 62,523,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Segment | Latin America And Other Business Segments | 22,993,000 | USD | 0000275053-21-000002 |
| FY 2019Yearly · 2019-12-31 | Segment | North America Business | 138,163,000 | USD | 0000275053-21-000002 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Other Countries | 38,783,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Geography | South Korea | 18,528,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Geography | United States | 33,961,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Natures Sunshine Products Americas | 38,667,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Natures Sunshine Products China | 6,253,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Natures Sunshine Products Russia Central And Eastern Europe | 11,358,000 | USD | 0001628280-19-006455 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Synergy World Wide | 34,994,000 | USD | 0001628280-19-006455 |
| FY 2018Yearly · 2018-12-31 | Geography | Other Countries | 158,926,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Geography | South Korea | 72,207,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 133,677,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Segment | Latin America And Other | 25,201,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Segment | Natures Sunshine Products Americas | 139,031,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Segment | Natures Sunshine Products Russia Central And Eastern Europe | 56,314,000 | USD | 0000275053-20-000009 |
| FY 2018Yearly · 2018-12-31 | Segment | Synergy World Wide | 144,264,000 | USD | 0000275053-20-000009 |
| Q4 2018Quarterly · 2018-12-31 | Geography | Other Countries | 45,275,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Geography | South Korea | 19,744,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Geography | United States | 32,355,000 | USD | Legacy provider |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.